Spontaneous and antigen-induced chemokine production in exposed but uninfected partners of HIV type 1-infected individuals in North India

AIDS Research and Human Retroviruses

Volumn 23, Issue 2, 2007, Pages 261-268

  Suresh, P ^a   Wanchu, Ajay ^a   Bhatnagar, Archana ^b   Sachdeva, Ravinder Kaur ^a   Sharma, Meera ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

^b PANJAB UNIVERSITY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA CHEMOKINE; ANTIGEN P24; BETA CHEMOKINE; CHEMOKINE; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; PHYTOHEMAGGLUTININ; RANTES; STROMAL CELL DERIVED FACTOR 1ALPHA;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; EXPOSURE; FEMALE; HIGH RISK POPULATION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; IMMUNOSTIMULATION; INFECTION RESISTANCE; MALE; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; STRUCTURAL GENE; SUPERNATANT; VIRUS GENE;

ADULT; ANTIGENS, VIRAL; CASE-CONTROL STUDIES; CHEMOKINES, CC; CHEMOKINES, CXC; FEMALE; HIV CORE PROTEIN P24; HIV INFECTIONS; HIV SERONEGATIVITY; HIV-1; HUMANS; IMMUNITY, NATURAL; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; PHYTOHEMAGGLUTININS; RANTES; T-LYMPHOCYTES;

EID: 33947228030     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.2006.0146     Document Type: Article

References (37)

1. Rowland-Jones S and McMichael A: Immune responses in HIV exposed seronegatives: Have they repelled the virus? Curr Opin Immunol 1995;7:448-455.
2. Heeney JL, Beverley P, McMichael A, et al.: Immune correlates of protection from HIV and AIDS-more answers but yet more questions. Immunol Today 1999;20:247-251.
3. Smith DK, Grohskopf LA, Black RJ, et al.: Antiretroviral postexposure prophylaxis after sexual, injection-drug use, or other nonoccupational exposure to HIV in the United States: Recommendations from the U.S. Department of Health and Human Services. MMWR Recomm Rep 2005;54(RR-2):1-20.
4. MacDonald KS, Fowke KR, Kimani J, et al.: Influence of HLA supertypes on susceptibility and resistance to human immunodeficiency virus type 1 infection. J Infect Dis 2000;181:1581-1589.
5. Beyrer C, Artenstein AW, Rugpao S, et al.: Epidemiologic and biologic characterization of a cohort of human immunodeficiency virus type 1 highly exposed, persistently seronegative female sex workers in northern Thailand. Chiang Mai HEPS Working Group. J Infect Dis 1999;179:59-67.
6. Sriwanthana B, Hodge T, Mastro TD, et al.: HIV-specific cytotoxic T lymphocytes, HLA-A11, and chemokine-related factors may act synergistically to determine HIV resistance in CCR5 delta32-negative female sex workers in Chiang Rai, northern Thailand. AIDS Res Hum Retroviruses 2001;17:719-734.
7. Skurnick JH, Palumbo P, DeVico A, et al.: Correlates of non-transmission in US women at high risk of human immunodeficiency virus type 1 infection through sexual exposure. J Infect Dis 2002;185:428-438.
8. Suresh P, Wanchu A, Sachdeva RK, and Bhatnagar A: Gene polymorphisms in CCR5, CCR2, CX3CR1, SDF-1 and RANTES in exposed but uninfected partners of HIV-1 infected individuals in north India. J Clin Immunol (available online at: http://dx.doi.org/10.1007/s10875-006-9036-0).
9. Furci L, Scarlatti G, Burastero S, et al.: Antigen-driven C-C chemokine-mediated HIV-1 suppression by CD4+ T cells from exposed uninfected individuals expressing the wild-type CCR5 allele. J Exp Med 1997;186:455-460.
10. Charo IF and Ransohoff RM: The many roles of chemokines and chemokine receptors in inflammation. N Engl J Med 2006;354: 610-621.
11. Alkhatib G, Combadiere C, Broder CC, et al.: CC CKR5: A RANTES, MIP-1alpha, MIP-1beta receptor as a fusion cofactor for macrophage-tropic HIV-1. Science 1996;272:1955-1958.
12. Deng H, Liu R, Ellmeier W, et al.: Identification of a major co-receptor for primary isolates of HIV-1. Nature 1996;381:661-666.
13. Doranz BJ, Rucker J, Yi Y, et al.: A dual-tropic primary HIV-1 isolate that uses fusin and the beta-chemokine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors. Cell 1996;85: 1149-1158.
14. Hernanz-Falcon P, Rodriguez-Frade JM, et al: Identification of amino acid residues crucial for chemokine receptor dimerization. Nat Immunol 2004;5:216-223.
15. Rodriguez-Frade JM, del Real G, Serrano A, et al.: Blocking of HIV infection via CCR5 and CXCR-4 receptors by acting in trans on the CCR2 chemokine receptor. EMBO J 2004;23:66-76.
16. Vila-Coro AJ, Rodriguez-Frade JM, Martin De Ana A, Moreno-Ortiz MC, Martinez-AC, and Mellado M: The chemokine SDF-1 alpha triggers CXCR4 receptor dimerization and activates the JAK/STAT pathway. FASEB J 1999;13:1699-1710.
17. Choe H, Farzan M, Sun Y, et al.: The beta-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates. Cell 1996;85:1135-1148.
18. Deng H, Liu R, Ellmeier W, et al.: Identification of a major co-receptor for primary isolates of HIV-1. Nature 1996;381:661-666.
19. Zagury D, Lachgar A, Chams V, et al.: C-C chemokines, pivotal in protection against HIV type 1 infection. Proc Natl Acad Sci USA 1998;95:3857-3861.
20. Wasik TJ, Bratosiewicz J, Wierzbicki A, et al.: Protective role of beta-chemokines associated with HIV-specific Th responses against perinatal HIV transmission. J Immunol 1999;162:4355-4364.
21. Ullum H, Cozzi Lepri A, Victor J, et al. Production of beta-chemokines in human immunodeficiency virus (HIV) infection: Evidence that high levels of macrophage inflammatory protein-1 beta are associated with a decreased risk of HIV disease progression. J Infect Dis 1998;177:331-336.
22. Garzino-Demo A, Moss RB, Margolick JB, et al.: Spontaneous and antigen induced production of HIV inhibitory β-chemokines are associated with AIDS free status. Proc Natl Acad Sci USA 1999;96:11986-11991.
23. Rosenberg ES, Billingsley JM, Caliendo AM, et al.: Vigorous HIV-1-specific CD4+ T cell responses associated with control of viremia. Science 1997;278:1447-1450.
24. Cocchi F, DeVico AL, Garzino-Demo A, Arya SK, Gallo RC, and Lusso P.: Identification of RANTES, MIP-1 alpha and MIP-1 beta as the major HIV suppressive factors produced by CD8+ T cells. Science 1995;270:1811-1815.
25. Iqbal SM, Ball TB, Kimani J, et al.: Elevated T cell counts and RANTES expression in the genital mucosa of HIV-1-resistant Kenyan commercial sex workers. J Infect Dis 2005;192:728-738.
26. Shieh B, Yan YP, Ko NY, et al.: Detection of elevated serum beta-chemokine levels in seronegative Chinese individuals exposed to human immunodeficiency virus type 1. Clin Infect Dis 2001;33: 273-279.
27. Skurnick JH, Palumbo P, DeVico A, et al.: Correlates of non-transmission in US women at high risk of human immunodeficiency virus type 1 infection through sexual exposure. J Infect Dis 2002;185:428-438.
28. Clerici M, Via CS, Lucey DR, Roilides E, Pizzo PA, and Shearer GM: Functional dichotomy of CD4+ T helper lymphocytes in asymptomatic human immunodeficiency virus infection. Eur J Immunol 1991;21:665-670.
29. Shearer GM and Clerici M: How human immunodeficiency virus ravages the immune system. Curr Opin Immunol 1992;4:463-465.
30. Butera ST, Pisell TL, Limpakarnjanarat K, et al.: Production of a novel viral suppressive activity associated with resistance to infection among female sex workers exposed to HIV type 1. AIDS Res Hum Retroviruses 2001;17:735-744.
31. Mazzoli S, Trabattoni D, Lo Caputo S, et al.: HIV-specific mucosal and cellular immunity in HIV-seronegative partners of HIV-seropositive individuals. Nat Med 1997;3:1250-1257.
32. Barretina J, Blanco J, Gutierrez A, et al.: Evaluation of the putative role of C-C chemokines as protective factors of HIV-1 infection in seronegative hemophiliacs exposed to contaminated hemoderivatives. Transfusion 2000;40:461-467.
33. Paxton WA, Martin SR, Tse D, O'Brien TR, Skurnick J, VanDevanter NL, et al.: Relative resistance to HIV-1 infection of CD4 lymphocytes from persons who remain uninfected despite multiple high-risk sexual exposure. Nat Med 1996;2:412-417.
34. Paxton WA, Liu R, Kang S, et al.: Reduced HIV-1 infectability of CD4+ lymphocytes from exposed-uninfected individuals: Association with low expression of CCR5 and high production of beta-chemokines. Virology 1998;244:66-73.
35. Zhu T, Corey L, Hwangbo Y, et al.: Persistence of extraordinarily low levels of genetically homogeneous human immunodeficiency virus type 1 in exposed seronegative individuals. J Virol 2003; 77:6108-6116.
36. Xiao L, Weiss SH, Qari SH, et al.: Partial resistance to infection by R5X4 primary HIV type 1 isolates in an exposed-uninfected individual homozygous for CCR5 32-base pair deletion. AIDS Res Hum Retroviruses 1999;15:1201-1208.
37. Ramalingam S, Kannangai R, Vijayakumar TS, et al.: Increased number of CCR5+ CD4 T cells among south Indian adults probably associated with low frequency of X4 phenotype of HIV-1 in India. Indian J Med Res 2002;116:90-95.